电邮这篇文章 POLYMORPHISM OF NITROGEN OXIDE SYNTHESIS GENES (NO), AS A PREDICTOR OF FORMATION OF CARDIO- VASCULAR PATHOLOGY
- 作者: Peven O.S1, Zelikova A.L1, Pyatibrat E.D1
-
隶属关系:
- S.M. Kirov Military Medical Academy of the Ministry of Defense
- 期: 卷 39, 编号 1-1S (2020)
- 页面: 114-116
- 栏目: Articles
- URL: https://journal-vniispk.ru/RMMArep/article/view/43370
- DOI: https://doi.org/10.17816/rmmar43370
- ID: 43370
如何引用文章
全文:
详细
Spend a genetic analysis of the blood of 41 patients with using polymerase chain reaction (PCR) to detect the presence of a mutation in the nitric oxide synthase (NO) genes. All patients were clinically diagnosed with diseases of the cardiovascular system. Among the patietnts there are a part of them, based on an anamnesis, that have a relationship between the genetic predisposition and the presence of cardiovascular diseases which were also observed in parents and grandparents of the examined patients. During the study there were 2 polymorphic variants of genes of type III synthase nitric oxide (NOS3, endothelial or eNOS) - T786C and G894T. As a result there were revealed that 70% of the patients have a mutation of at least one of the polymorphic variants of the NOS3 genes and only 30% of the patients have a “ normal” allels, which indicates that there is a relationship between genetic mutations of nitric oxide synthase (NO) and an increased risk of developing diseases of the cardiovascular system in patients, in particular, such as neurocirculatory asthenia, hypertension, coronary heart disease. Besides there are a relationship between polymorphism of nitric oxide synthase genes (NOS3 or eNOS) and the risk of developing a pathology such as stroke, which is a prognostically unfavorable sign and it can lead to aggravation of concomitant diseases of the cardio-vascular system and the development of their complications, also it can lead to a decrease in the quality and life expectancy of patients. A decrease in the synthesis of nitric oxide (NO) affects the physiological properties of platelets which is manifested by a high risk of blood clots and an increase in mortality among patients.
作者简介
O. Peven
S.M. Kirov Military Medical Academy of the Ministry of DefenseSt. Petersburg, Russia
A. Zelikova
S.M. Kirov Military Medical Academy of the Ministry of DefenseSt. Petersburg, Russia
E. Pyatibrat
S.M. Kirov Military Medical Academy of the Ministry of DefenseSt. Petersburg, Russia
参考
- Бушуева, О.Ю. Гендерные различия полиморфизма Е298D гена эндотелиальной синтазы оксида азота и риск развития инсульта / О.Ю. Бушуева [и др.] // Клиническая медицина. - 2015. - Т.93, №2. - С.34-40.
- Воронина, Л.П. Полиморфизм гена эндотелиальной синтазы оксида азота / Л.П. Воронина, И.В. Севостьянова, О.С. Полунина // Астраханский медицинский журнал. - 2011. - Т.6, №2. - С.47-49.
- Камилова, У.К. Изучение полиморфизма генов NО-синтазы и уровня показателей эндогенного оксида азота у больных с хрониче-ской сердечной недостаточностью / У.К. Камилова, Л.И. Юнусова // Сборник тезисов Юбилейной всероссийской научно-практической конференции «Достижения современной кардиологии». - 2015. - С.21-22.
- Урясьев, О.М. Роль полиморфизма синтаз оксида азота в формировании коморбидной патологии - бронхиальной астмы и гипер-тонической болезни / О.М. Урясьев, А.В. Шаханов // Казанский медицинский журнал. - 2017. - Т.98, №2. - С.226-232.
- Шенкман, Б.С. Нейрональная NO-синтаза - молекулярный гарант стабильности мышечного волокна. NO-зависимые сигнальные пути в активной и разгруженной мышце / Б.С. Шенкман, Ю.В. Ломоносова, Т.Л. Немировская // Успехи физиологических наук. - 2015. - С.37-39.
- Шуклин, А.В. NO-синтаза во внутрисердечных ганглиях человека в норме и при ишемии миокарда / А.В. Шуклин, Н.В. Швалев. - М.: Российский кардиологический научно-производственный комплекс Росздрава, 2006. - С.34-36.
- Forstermann, U. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions / U. Forstermann, E.I. Closs, J.S. Pollock [et al.] // Hypertension. - 1994. - Vol.23. - P.1121-1131.
补充文件
